Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2005
05/05/2005US20050095703 Generating progenitor cells for use in prevention and treatment of cell proliferative, neurodegenerative and pancreatic disorders; regenerative medicine; tissue engineering
05/05/2005US20050095297 Nanoparticulate formulations of fenofibrate
05/05/2005US20050095262 Multivitamin syrup for children or young adults
05/05/2005US20050095248 Use of inhibitor of cathepsin S based upon peptide sequence which comprises at least about 2-20 consecutive residues from preferred invariant chain cleavage site of cathepsin S, spanning from residue 68 to residue 90 of specified sequence
05/05/2005US20050095238 Treating a disease associated with leukocyte infiltration of mucosal tissues, such as inflammatory bowel disease, asthma, graft vs host disease, pancreatitis, diabetes, or sinutitis with a humanized immunoglobulin or antigen-binding fragment thereof having binding specificity for alpha 4 beta 7 integrin
05/05/2005US20050095229 Comprises conduit connected to blood pool, cell culture for producing analyte (insulin, glucagons, and/or somatostatin), and concentration controller (integrated circuit)
05/04/2005EP1528066A1 Aryl 5-thio-d-glucopyranoside derivatives and remedies for diabetes containing the same
05/04/2005EP1528058A1 Polymorphic crystalline forms of celecoxib
05/04/2005EP1527159A1 Probiotic propionibacterium jensenii 702
05/04/2005EP1527070A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
05/04/2005EP1527068A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof
05/04/2005EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
05/04/2005EP1526895A2 Methods for treating carbonic anhydrase mediated disorders
05/04/2005EP1526894A1 Use of a ppar-alpha agonist to treat weight gain associated with a ppar-gamma agonist treatment
05/04/2005EP1526869A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia
05/04/2005EP1526860A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
05/04/2005EP1526857A1 Cholesterol-reducing agent made of dietary fibre and cholesterol-reducing substances
05/04/2005EP1526851A2 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
05/04/2005EP1526847A2 Pharmaceutical dosage form comprising a sulfite compound
05/04/2005EP1526846A2 Gelatin capsule exhibiting reduced cross-linking
05/04/2005EP1526845A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage
05/04/2005EP1526844A2 Pellicle-resistant gelatin capsule
05/04/2005EP1465504B1 Matrix-forming composition containing pectin
05/04/2005EP1465493A4 Cultured and encapsulated pancreatic stem cells
05/04/2005EP1448553B1 N-heterocyclyl hydrazides as neurotrophic agents
05/04/2005EP1411881B1 5ht2c receptor modulators
05/04/2005EP1395582B1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
05/04/2005EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors
05/04/2005EP1246790B1 Substituted 1 and 2 naphthol mannich bases
05/04/2005EP1180519B1 Hydrochloride of fused-heterocycle compound
05/04/2005EP1140830B1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5ht1a receptor activity
05/04/2005EP1119567B1 Quinazoline derivatives
05/04/2005EP1023067B1 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
05/04/2005EP0958280B1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
05/04/2005EP0886637B9 Inhibitors of microsomal triglyceride transfer protein and method
05/04/2005CN2696636Y Oral minrature grain of insulin
05/04/2005CN1613012A Soluble cd40l (cd154) as a prognostic marker of atherosclerotic diseases
05/04/2005CN1612939A Highly sensitive and continuous protein tyrosine phosphatase test using 6, 8-difluoro-4-methylumbelliferyl phosphate
05/04/2005CN1612893A VEGF peptides and their use for inhibiting angiogenesis
05/04/2005CN1612877A Spiroazacyclic compounds as monoamine receptor modulators
05/04/2005CN1612875A 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active
05/04/2005CN1612874A Rosiglitazone edisylates and their use as antidiabetics
05/04/2005CN1612873A 4-2-n-methyl-n-2-pyridylamidoethoxybenzylthiazolidine-2, 4-dione and pharmaceutical compositions comprising the same
05/04/2005CN1612872A Process for the preparation of simvastatin
05/04/2005CN1612869A Novel 1, 2, 4-thiadiazolium derivatives as melanocortin receptor modulators
05/04/2005CN1612859A Crystalline (r-(r*, r*))-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-heptanoic acid calcium salt (2:1)
05/04/2005CN1612852A Lipoxin A4 analogs
05/04/2005CN1612746A Use of HEPCIDIN as a regulator of iron homeostasis
05/04/2005CN1612745A Methods for slowing senescence and treating and preventing diseases associated with senescence
05/04/2005CN1612742A Composition and method
05/04/2005CN1612733A Benzimidazoles useful as protein kinase inhibitors
05/04/2005CN1612730A Medicinal composition containing 2, 2-dichloro-12-(4-chlorophenyl)dodecanoic acid
05/04/2005CN1612698A Modified methionine rich food products and process for their manufacture
05/04/2005CN1611598A Human foetus pancreatic stem cell line and its establishing method
05/04/2005CN1611489A Intermediates for the synthesis of benzimidazole compounds and process for preparation thereof
05/04/2005CN1611255A Novel preparation of thristy-removing pill
05/04/2005CN1611254A American ginseng fruit, and its medicinal composition and pharmaceutical use
05/04/2005CN1611247A Chinese medicine injection liquid for treating cerebro-cardio vascular disease and diabetes
05/04/2005CN1611243A Gastrodia-pseudo-ginseng micro-powder composition
05/04/2005CN1611241A Chinese medicine capsule for regulating blood sugar
05/04/2005CN1611238A Bamboo-shoot juice and its preparing method and use
05/04/2005CN1611233A Pollen oral disintegrating tablet
05/04/2005CN1611221A Injection liquid containing alprostadic and its production process
05/04/2005CN1200090C Ostrica bone medicinal liquor and preparation method thereof
05/04/2005CN1200000C Cyclie somatostatin analogs
05/04/2005CN1199993C N-terminal deletion lipocyte complement related protein and its preparation method
05/04/2005CN1199959C Percyquuinnin, process for its production and its use pharmaceutical
05/04/2005CN1199954C Benzodiazepine derivatives
05/04/2005CN1199694C Application of composite fat used as stabilizing additive in medicine of digestive enzyme mixture
05/04/2005CN1199683C Medicine composition for reducing blood fat and preventing senescence and its medicines
05/04/2005CN1199673C A pharmaceutical composition for treating diabetes and insuline resistance syndrome
05/04/2005CN1199634C Hypoglycemic skin care cream for II diabetes patient and its production process
05/04/2005CN1199584C Healthy food for balancing blood pressure and regulating blood fat and preparing method thereof
05/04/2005CN1199576C Balsam pear saccharide capable of regulating blood sugar and its production process
05/03/2005US6888016 For therapy of insulin resistance; for stimulating the glucose up-take in adipocytes
05/03/2005US6888004 Imidazolyl derivatives as corticotropin releasing factor inhibitors
05/03/2005US6887998 Process for 8-carboxamido-2,6-methano-3-benzazocines
05/03/2005US6887996 Compounds and their use
05/03/2005US6887905 Treatment of depression or generalized anxiety disorder
05/03/2005US6887897 Therapy for kidney disease; complexing phosphorus with calcium glutarate ; prevent forming kidney stones
05/03/2005US6887894 Use of lipoic acid for improving the bioavailability of mineral salts
05/03/2005US6887893 Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia
05/03/2005US6887892 Tricyclic derivatives of indole with antiangiogenic activity
05/03/2005US6887889 Aryl and biaryl piperdines with MCH modulatory activity
05/03/2005US6887884 For therapy of neurological and psychological disorders
05/03/2005US6887874 For producing an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal; therapy of cancer, rheumatoid arthritis
05/03/2005US6887872 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
05/03/2005US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia
05/03/2005US6887868 Therapeutic 5-HT ligand compounds
05/03/2005US6887865 N-heterocyclic derivatives as NOS inhibitors
05/03/2005US6887844 To stimulate the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM)
05/03/2005US6887670 For drug screening; solid phase synthesis; fusion proteins; genetic engineering
05/03/2005US6887501 Isolated from cocoa beans; solvent extraction; nitric oxide synthase/lipoxygenase/cyclooxygenase modulators
05/03/2005US6887463 Recombinant viral vector encoding a human very low density lipoprotein (VLDL) receptor, operatively linked to regulatory sequences directing expression in a hepatocyte; familial hypercholesterolemia or hyperlipidemia
05/03/2005CA2147623C Novel p-selectin ligand protein
05/03/2005CA2103189C Tetracyclines including non-antimicrobial chemically-modified tetracyclines inhibit excessive collagen crosslinking during diabetes
04/2005
04/28/2005WO2005037839A1 Norcantharidin derivative compounds, method for the production thereof, compositions containing said compounds and the use thereof
04/28/2005WO2005037286A1 Use of pteridine derivatives for the treatment of increased intracranial pressure and secondary ischemia
04/28/2005WO2005036990A1 Composition for prevention, inhibition and treatment of obesity and related diseases
04/28/2005WO2005036989A1 Health food containing hyaluronic acid and dermatan sulfate
1 ... 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 ... 1298